“New Science” is Driving More Growth than Predicted Against a Changing Economic Environment, According to Accenture Report

An Accenture Report

New Science is expected to deliver 81 percent of industry revenue growth between 2021 and 2026
Biopharma companies should streamline treatment discovery, development and commercialization and share the value with customers